PDSB Price / Book | PDS Biotechnology Corp

PDS Biotechnology Corp (PDSB) Price / Book

2026-03-31: Price/Book Ratio 8.67.
2025-12-31: Price/Book Ratio 4.57.
2025-09-30: Price/Book Ratio 5.1.
2025-06-30: Price/Book Ratio 3.89.

Historical market capitalization divided by filed shareholder equity.

Available history: 2015-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-03-31	8.67
2025-12-31	4.57
2025-09-30	5.1
2025-06-30	3.89
2025-03-31	2.42
2024-12-31	3.26
2024-09-30	6.39
2024-06-30	3.49
2024-03-31	3.91
2023-12-31	6.29
2023-09-30	6.4
2023-06-30	4.79
2023-03-31	4.61
2022-12-31	9.05
2022-09-30	1.8
2022-06-30	2.02
2022-03-31	3.15
2021-12-31	3.65
2021-09-30	6.24
2021-06-30	4.89
2021-03-31	4.16
2020-12-31	1.76
2020-09-30	1.67
2020-06-30	1.81
2020-03-31	0.56
2019-12-31	1.2
2019-09-30	1.14
2019-06-30	1.51
2019-03-31	1.57
2017-09-30	88.71
2017-06-30	75.07
2017-03-31	67.21
2016-12-31	80.98
2016-09-30	61.74
2016-06-30	54.64
2016-03-31	45.96
2015-12-31	58.81

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
SCYNEXIS INC (SCYX)	United States	$0.045B
Grace Therapeutics, Inc. (GRCE)		$0.046B	-1.83
VERU INC. (VERU)	United States	$0.043B	-3.93
Werewolf Therapeutics, Inc. (HOWL)	United States	$0.047B
Kairos Pharma, LTD. (KAPA)	United States	$0.041B
Dogwood Therapeutics, Inc. (DWTX)	United States	$0.049B
Lite Strategy, Inc. (LITS)	United States	$0.049B
Incannex Healthcare Inc. (IXHL)		$0.040B	-22.32
Elicio Therapeutics, Inc. (ELTX)	United States	$0.049B
Karyopharm Therapeutics Inc. (KPTI)	United States	$0.039B	-0.98